Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.5 (EPT/RI)Replacement Pfizer INC

8 May 2014 10:13

RNS Number : 5903G
Morgan Stanley Securities Limited
08 May 2014
 



AMENDMENT

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

29 APRIL 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 312,500

 18.9547 GBP

 18.9547 GBP

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 SHORT

 79

 22.9168 EUR

 COMMON STOCK

 CFD

 SHORT

 300

 23.0008 EUR

 COMMON STOCK

 CFD

 LONG

 2,567

 31.9888 USD

 COMMON STOCK

 CFD

 LONG

 40,215

 31.9888 USD

COMMON STOCK

 CFD

 LONG

 165

 211.0000 SEK

COMMON STOCK

 CFD

 SHORT

 130

 207.0000 SEK

COMMON STOCK

 CFD

 SHORT

 165

 209.5000 SEK

COMMON STOCK

 CFD

 SHORT

 15

 209.5000 SEK

 COMMON STOCK

 CFD

 LONG

 1,827

 31.7330 USD

 COMMON STOCK

 CFD

 LONG

 884

 32.0600 USD

 COMMON STOCK

 CFD

 LONG

 5,382

 32.0600 USD

 COMMON STOCK

 CFD

 SHORT

 500

 31.6400 USD

 COMMON STOCK

 CFD

 SHORT

 1,915

 31.7600 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

06 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERUGUPGAUPCUBR
Date   Source Headline
11th Nov 20153:04 pmRNSForm 8.3 - Pfizer Inc
11th Nov 20152:59 pmRNSForm 8.3 - Pfizer Inc Amendment
11th Nov 20152:44 pmRNSForm 8.3 - Allergan Plc
11th Nov 20151:45 pmRNSForm 8.1(a) - Pfizer Inc.
11th Nov 201512:45 pmRNSForm 8.3 - Allergan plc
11th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
11th Nov 201511:52 amRNSForm 38.5(b) - Pfizer Inc
11th Nov 201511:01 amRNSRule 38.5 - Pfizer INC
11th Nov 201510:47 amRNSForm 8.1 - [Pfizer Inc]
11th Nov 201510:44 amRNSForm 38.5b
11th Nov 201510:41 amRNSForm 38.5a
10th Nov 20155:19 pmRNSRule 38.5 - Replacement Pfizer INC
10th Nov 20153:29 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20153:23 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
10th Nov 20153:12 pmRNSForm 8.3 - Allergan plc
10th Nov 20153:04 pmRNSForm 8.3 - Pfizer Inc
10th Nov 20152:54 pmRNSForm 8.3 - Pfizer, Inc.
10th Nov 20152:45 pmRNSForm 8.3 - Allergan Plc
10th Nov 20152:31 pmRNSForm 8.3 - ALLERGAN PLC
10th Nov 20152:28 pmRNSForm 8.3 - PFIZER INC
10th Nov 20152:12 pmBUSForm 8.3 - Pfizer Inc.
10th Nov 201512:35 pmRNSForm 38.5(b) - Pfizer Inc
10th Nov 201512:13 pmRNSForm 38.5b
10th Nov 201512:10 pmRNSForm 38.5b
10th Nov 201512:05 pmRNSForm 38.5a
10th Nov 201512:02 pmRNSForm 8.1 - [Pfizer Inc]
10th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
10th Nov 201511:16 amRNSRule 38.5 - Pfizer INC
10th Nov 201511:11 amRNSRule 38.5 - Replacement Pfizer INC
10th Nov 201511:10 amRNSRule 38.5 - Replacement Pfizer INC
9th Nov 20154:30 pmRNSForm 8.3 - Allergan plc
9th Nov 20153:44 pmRNSForm 8.3 - PFIZER INC
9th Nov 20153:33 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20153:25 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20153:24 pmRNSForm 8.3 - Pfizer Inc Amendment
9th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
9th Nov 20152:58 pmRNSForm 8.3 - ALLERGAN PLC
9th Nov 20152:48 pmRNSForm 8.3 - Pfizer, Inc.
9th Nov 20152:37 pmRNSForm 8.3 - Pfizer Inc
9th Nov 20152:26 pmRNSForm 8.3 - Allergan Plc
9th Nov 201512:02 pmRNSForm 38.5b
9th Nov 201511:59 amRNSForm 38.5b
9th Nov 201511:56 amRNSForm 38.5a
9th Nov 201511:55 amRNSForm 8.1 - [Pfizer Inc]
9th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
9th Nov 201511:41 amRNSForm 38.5(b) - Pfizer Inc.
9th Nov 201510:58 amRNSRule 38.5 - Pfizer INC
9th Nov 201510:56 amRNSRule 38.5 - Pfizer INC
6th Nov 20154:16 pmRNSRule 38.5 - Replacement Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.